Leases and TFRS #9 financial instruments have been adopted since 2020, which impacted our net profit leading to a decrease of THB 250 million. Financial summary for 3 months period ended June 2020 and June
IPUX Website: www.ipux.io/en/, FB: IPUX : Unapproved public offering of digital token (Disclosure Date : 27/12/2018)
Ultron-Mavie TH : Unlicensed digital asset businessUnapproved public offering of digital token (Disclosure Date : 15/01/2024)
Ox.Cash : Unapproved public offering of digital tokenUnlicensed digital asset business (Disclosure Date : 23/09/2022)
Ultron-Mavie TH : Unlicensed digital asset businessUnapproved public offering of digital token (Disclosure Date : 15/01/2024)
Ox.Cash : Unapproved public offering of digital tokenUnlicensed digital asset business (Disclosure Date : 23/09/2022)
Consolidated financial statements Change Increase/(Decrease) For Three Months Ended 30 June 2020 30 September 2020 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1
1,674.44 million and THB 1,249.63 million respectively, slipping significantly at a rate of 25.37%. The slump in international sales revenue is still accountable for the decrease in sales revenue as
Performance for the 3 months period ended March 31, 2020 as follows: Unit : Million Baht March 31, 2020 March 31, 2019 Increase (Decrease) Amount % Amount % Amount % Revenues from dental service 112.83 96.38
consolidated operating revenue of THB 137 million in Q2/2021 and THB 317 million in 1H/2021, decreased by 5% from Q2/2020 and 13% from 1H/2020, respectively. • The decrease was mainly from the decline in